![](/img/cover-not-exists.png)
A Phase 3, randomized, double-blind study of single-dose fosaprepitant for prevention of cisplatin-induced nausea and vomiting: Results of an Indian population subanalysis
Maru, A, Gangadharan, VP, Mohapatra, RK, Carides, AD, Desai, CJVolume:
50
Year:
2013
Language:
english
Journal:
Indian Journal of Cancer
DOI:
10.4103/0019-509X.123580
File:
PDF, 438 KB
english, 2013